Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of MDX-1100, a Fully Human Anti-CXCL10 Monoclonal Antibody, in Combination With Methotrexate in Patients With Rheumatoid Arthritis
This disruption helps the primary preservative system in a product work more effectively at lower doses
Our team walks you through every step so you feel confident from day one
Preferred drugs are usually less expensive or have no suitable alternatives
.png)
Medzhitov, R
253 : 872879 Slemmon JR
US$ 24.07
US$ 25.51
US$ 20.35
